Aktis Oncology, Inc. (AKTS)

CIK 2035832 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aktis Oncology, Inc..

Recent SEC filings

FiledFormAccession number
Aug 13, 202610-Q0001193125-26-349144
Aug 13, 20268-K0001193125-26-349133
Jul 21, 202640001193125-26-310991
Jul 20, 20261440001950047-26-007234
Jul 20, 202640001193125-26-309115
Jul 17, 20261440001950047-26-007199
Jul 10, 202640001193125-26-300163
Jul 10, 202640001193125-26-300162
Jul 8, 20261440001950047-26-006961
Jul 8, 20261440001950047-26-006960
May 14, 2026SCHEDULE 13G0001140361-26-021340
May 11, 202610-Q0001193125-26-216749
May 11, 20268-K0001193125-26-216716
Apr 16, 202640001193125-26-159028
Apr 16, 20268-K0001193125-26-158944
Apr 16, 202630001193125-26-158968
Mar 31, 20268-K0001193125-26-132524
Mar 30, 202610-K0001193125-26-131748
Jan 20, 2026SCHEDULE 13D0001231919-26-000070
Jan 20, 2026SCHEDULE 13D0000935836-26-000046
Jan 15, 202630001193125-26-013467
Jan 15, 2026SCHEDULE 13D0001193125-26-013469
Jan 14, 202640001231919-26-000057
Jan 14, 2026SCHEDULE 13D0001193125-26-013015
Jan 14, 202640001473930-26-000005